Alzheimer Disease Drugs Markets in China

Published: May, 2016 | Pages: 239 | Publisher: Asia Market Information & Development Company
Industry: Pharmaceutical | Report Format: Electronic (PDF)

China's demand for Alzheimer Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2005, 2010 and 2015) and long-term forecasts through 2020 and 2025 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

 TABLE OF CONTENTS



I.  INTRODUCTION  

Report Scope and Methodology  
Executive Summary  

II. BUSINESS ENVIRONMENT  
  
Economic Outlook
  
Key Economic Indicators
Industrial Output  
Population and Labor   
Foreign Investment
Foreign Trade 
  
Financial and Tax Regulations

Banking System and Regulations  
Foreign Exchange   
Taxes, Tariff and Custom Duties  

III. ALZHEIMER'S DISEASE DRUGS INDUSTRY ASSESSMENTS  

Alzheimer's Disease Drugs Industry Structure
Market Size
Market Growth Drivers
Alzheimer's Disease Drugs Sales Volume  
Major Producer Facility Locations and Sales Volume 
Market Share of Key Producers  
Labor Cost
Potential Entrants
Major Distributors  
Major Foreign Investments  
Technology Development
  

IV.  ALZHEIMER'S DISEASE DRUGS PRODUCTION AND DEMAND  

Overview
Demand of Alzheimer's Disease Drugs by Region     
Alzheimer's Disease Drugs Sales Volume
Ginkgo Bilota Extract 
Breviscapine 
Ganglioside 
Donepezil 
Galanthamine 
Nicergoline 
Rivastigmine 
Memantine 
Huperzine A 
Oxiracetam 
Flunarizine 
Piracetam 
Other Alzheimer's Disease Drugs 
Alzheimer's Disease Drugs Imports
Ginkgo Bilota Extract Imports
Breviscapine Imports
Ganglioside Imports
Donepezil Imports
Galanthamine Imports
Nicergoline Imports
Rivastigmine Imports
Memantine Imports
Huperzine A Imports
Oxiracetam Imports
Flunarizine Imports
Piracetam Imports
Other Alzheimer's Disease Drugs Imports
Pricing Trend   
 
 V.  ALZHEIMER'S DISEASE DRUGS MARKET OUTLOOK        

Alzheimer's Disease Drugs Markets Outlook Overview  
Government Regulations
Health Care Insurance Industry Overview
Consumer Spending Trends By Region
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits       

V. MARKETING STRATEGIES  

  China Market Entry Overview  
   China's Distribution System   
   Rubber Processing Chemicals Distribution Channels  
   Transportation and Freight Infrastructure
   Communications  
  China's Market Entry
         Licensing
 Franchising
 E-commerce
 Trading Companies and Local Agents
 Representative Offices and Chinese Subsidiaries
 Wholly Foreign Owned Enterprises



VII. ALZHEIMER'S DISEASE DRUGS PRODUCER DIRECTORY

Major Alzheimer's Disease Drugs Producer Profiles
Distributors and Trading Companies
Associations and Research Institutes
Major End-Users













List of Tables


 I. INTRODUCTION  

Economic Outlook Summary
    
 II. BUSINESS ENVIRONMENT  
 
Key Economic Indicators   
Industrial Output  
Population and Labor Force Trends  
Foreign Investment and Loans  
Foreign Trade  
    
 III. ALZHEIMER'S DISEASE DRUGS INDUSTRY ASSESSMENTS  

Alzheimer's Disease Drugs Sales Volume  
Major Producer Facility Locations  
Major Alzheimer's Disease Drugs Producer Sales Volume  
Market Share of Key Producers  
Major Foreign Investments  

 IV. ALZHEIMER'S DISEASE DRUGS PRODUCTION AND DEMAND 
 
Total Alzheimer's Disease Drugs Sales Volume  
Alzheimer's Disease Drugs Major Producer and Their Market Share
Ginkgo Bilota Extract Major Producer and Their Market Share
Breviscapine Major Producer and Their Market Share
Ganglioside Major Producer and Their Market Share
Donepezil Major Producer and Their Market Share
Galanthamine Major Producer and Their Market Share
Dihydroergotamine Major Producer and Their Market Share
Rivastigmine Major Producer and Their Market Share
Memantine Major Producer and Their Market Share
Huperzine A Major Producer and Their Market Share
Oxiracetam Major Producer and Their Market Share
Flunarizine Major Producer and Their Market Share
Piracetam Major Producer and Their Market Share
Alzheimer's Disease Drugs Import


 V.  ALZHEIMER'S DISEASE DRUGS MARKET OUTLOOK 
 
Consumer Spending Trend
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits 




































List of Charts


I.  INTRODUCTION
Alzheimer's Disease Drugs Sales Volume

II. BUSINESS ENVIRONMENT

China's GDP and Industrial Output  
Industrial Output by Ownership 
China's Imports and Exports

III. ALZHEIMER'S DISEASE DRUGS INDUSTRY ASSESSMENTS 

Alzheimer's Disease Drugs Sales Volume

II. ALZHEIMER'S DISEASE DRUGS PRODUCTION AND
DEMAND 
  
Alzheimer's Disease Drugs Sales Volume  
Worldwide Alzheimer's Disease Drugs Demand by Region
Ginkgo Bilota Extract Sales Volume and Market Share
Breviscapine Sales Volume and Market Share
Ganglioside Sales Volume and Market Share
Donepezil Sales Volume and Market Share
Galanthamine Sales Volume and Market Share
Dihydroergotamine Sales Volume and Market Share
Rivastigmine Sales Volume and Market Share
Memantine Sales Volume and Market Share
Huperzine A Sales Volume and Market Share
Oxiracetam Sales Volume and Market Share
Flunarizine Sales Volume and Market Share
Piracetam Sales Volume and Market Share
Other Alzheimer's Disease Drugs Sales volume and market share
Alzheimer's Disease Drugs Import Volume
Ginkgo Bilota Extract Import Volume and Market Share
Breviscapine Import Volume and Market Share
Ganglioside Import Volume and Market Share
Donepezil Import Volume and Market Share
Galanthamine Import Volume and Market Share
Dihydroergotamine Import Volume and Market Share
Rivastigmine Import Volume and Market Share
Memantine Import Volume and Market Share
Huperzine A Import Volume and Market Share
Oxiracetam Import Volume and Market Share
Flunarizine Import Volume and Market Share
Piracetam Import Volume and Market Share
Other Alzheimer's Disease Drugs Import Volume and Market Share

VI.  MARKETING STRATEGIES

China's Distribution Channel